P3 Health Partners Delivers $26M Q1 EBITDA, Converts $250M Debt
PIII•P3 Health Partners delivered $26 million of adjusted EBITDA in Q1 2026, driving a raised full-year outlook and a 15% year-over-year increase in MA funding rates. The company converted $250 million of debt into preferred equity but saw at-risk membership fall from 118,000 to 106,000.
1. Q1 Financial Performance
P3 Health Partners reported $26 million of adjusted EBITDA for Q1 2026, surpassing internal expectations and prompting management to raise the company’s full-year outlook based on continued momentum in core operations.
2. Payer Contract and Funding Rate Improvements
Negotiated enhancements in payer contracts drove a 15% year-over-year increase in Medicare Advantage funding rates and delivered a flat MA medical expense trend in Q1, outperforming the 7% industry average.
3. Balance Sheet Strengthening through Debt Conversion
The conversion of $250 million of outstanding debt into preferred equity has bolstered the company’s capital structure, providing greater long-term balance sheet flexibility and supporting future expansion of delegated services.
4. Membership Trends and Operational Challenges
At-risk membership declined from 118,000 to 106,000 year-over-year due to targeted portfolio actions, while management faces variability in claims development and full-year cost expectations as it seeks to expand delegation beyond the current 63% rate.
